Reliance Life Sciences Private Limited: Pemetrexed For Injection 500mg/vial, 1

Pemetrexed for Injection Recall Summary Reliance Life Sciences is recalling Pemetrexed for Injection 500mg/Vial (a cancer treatment medication) distributed nationwide under the brand Somerset Therapeutics because the manufacturer cannot guarantee the product is sterile. This is a Class II recall, meaning use of the product could cause serious harm or death. The affected product has NDC number 70069-0835-01 and was distributed to all U.S. states and Washington, D.C.

Recalling firm

Reliance Life Sciences Private Limited

Product

Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01

Reason

Lack of Sterility Assurance

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-06-24

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide in the USA

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/8e1453ef-de0f-4a8b-bd67-cdda56f3ad43